pharma · Advanced Solid Tumor
LaNova Medicines
LaNova Medicines Limited
LaNova Medicines is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Solid Tumor. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this e
Shanghai, CN HQ
2019 Founded
15 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Shanghai, CN
- Founded
- 2019
- Employees
- 15
- Programs
- 1
- Drugs
- 0
- Patents
- 0
LM-302
Phase 2 · small molecule · Advanced Solid Tumor
LM-302 for Advanced Solid Tumor is a Phase 2 program (small_molecule) at LaNova Medicines Limited with 1 ClinicalTrials.gov record(s).
Internal code LM302-01-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- LaNova Medicines Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced Solid Tumor
- Status
- completed
- Trials
- 1